Funding Opportunities

• AHRQ Mentored Research Scientist Career Development Award (K01)
  (PA-22-255)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): November 9, 2025
• Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R21 Clinical Trial Not Allowed)
  (PAR-22-236)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Application Receipt Date(s): November 16, 2024
• Advancing Methods for Safe, Noninvasive, Real Time Assessment of Placenta Development and Function Across Pregnancy (R01 Clinical Trial Not Allowed)
  (PAR-22-237)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Research on Women's Health
  Application Receipt Date(s): November 5, 2024
• NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (PAR-22-241)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 12, 2023
• Consortium for Design of TB Drug Regimens (UM1 Clinical Trial Not Allowed)
  (RFA-AI-22-059)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): February 7, 2023
• Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed)
  (RFA-DA-23-035)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 02, 2023
• BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
  (RFA-DA-23-039)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): September 12, 2024
• HEAL Initiative: HEAL Data2Action Innovation and Acceleration Projects, Phased Awards (R61/R33, Clinical Trial Optional)
  (RFA-DA-23-057)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 22, 2022
• HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed)
  (RFA-DA-23-058)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): November 22, 2022
• Diversity Centers for Genome Research (U54 Clinical Trials Optional)
  (RFA-HG-22-026)
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): June 24, 2024
• Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
  (RFA-HG-22-027)
  National Human Genome Research Institute
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): June 24, 2024
• Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
  (RFA-MH-22-270)
  National Institute of Mental Health
  Application Receipt Date(s): February 22, 2023
• Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
  (RFA-MH-22-271)
  National Institute of Mental Health
  Application Receipt Date(s): February 22, 2023
• Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC) (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-029)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 21, 2022
• Data Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - DCC) (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-030)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 21, 2022
• Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)
  (RFA-NS-22-031)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): November 21, 2022
• Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (UT1, UT2 Clinical Trail Not Allowed)
  (RFA-TR-22-031)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
• Botulinum Toxin Potency Assay using Tissue Chips (BoT PATCh) (U43/U44 - Clinical Trail Not Allowed)
  (RFA-TR-22-032)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.